A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG ‐asparaginase, and doxorubicin
Pediatric Blood&Cancer, EarlyView.
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: MatteoTrucco
,
Julio C.Barredo
,
JohnGoldberg
,
Gilles M.Leclerc
,
Gregory A.Hale
,
JonathanGill
,
BhuvanaSetty
,
TiffanySmith
,
RichardLush
,
Jae K.Lee
,
Damon R.Reed Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Dexamethasone | Fortamet | Leukemia | Metformin | Pediatrics